Suchergebnisse - "Rehal, Sunita"

1

Risk of selection bias in randomised trials

von: Kahan, Brennan C.

2015, in: Trials

Wird geladen...
2

Most noninferiority trials were not designed to preserve active comparator treatment effects

von: Tsui, Michael

2019, in: Journal of clinical epidemiology

Wird geladen...
3

A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma

von: van der Palen, Job

2022, in: Respiratory medicine

Wird geladen...
4

Reducing bias in open-label trials where blinded outcome assessment is not feasible: strategies from two randomised trials

von: Kahan, Brennan C

2014, in: Trials

Wird geladen...
5

Acute variceal haemorrhage in the United Kingdom: Patient characteristics, management and outcomes in a nationwide audit

von: Jairath, Vipul

2014, in: The relationship between physical performance and cardiac function in an elderly Russian cohort

Wird geladen...
6

Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome

von: Phillips, Patrick

2013, in: Trials

Wird geladen...
7

CONTINUED LARGE AMYLOID PET REDUCTIONS AT 36 MONTHS IN THE GANTENERUMAB OPEN-LABEL EXTENSION STUDIES

von: Klein, Gregory

2019, in: Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers

Wird geladen...
8

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis

von: Klein, Gregory

2019, in: Alzheimer's research & therapy

Wird geladen...
9

CORRELATION BETWEEN AMYLOID REDUCTION AND CLINICAL OUTCOMES: EXPLORATORY ANALYSES FROM THE GANTENERUMAB SCARLET ROAD AND MARGUERITE ROAD OPEN-LABEL EXTENSION STUDIES

von: Delmar, Paul

2019, in: Multi-objective optimization of the solar absorptivity distribution inside a cavity solar receiver for solar power towers

Wird geladen...
10

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

von: Boeree, Martin J

2017, in: Identification of Advanced Fibrosis in Hepatitis C Patients following Sustained Virologic Response: A New Predictive Model

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!